Kiora Pharmaceuticals Receives Grant from Choroideremia Research Foundation to Fund Novel Clinical Trial Endpoints for Inherited Retinal Diseases; Approval Granted to Initiate Clinical Validation Study

Encinitas, California--(Newsfile Corp. - April 11, 2024) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) has received grant funding from the Choroideremia Research Foundation (CRF) in [...]

Kiora Pharmaceuticals Receives Grant from Choroideremia Research Foundation to Fund Novel Clinical Trial Endpoints for Inherited Retinal Diseases; Approval Granted to Initiate Clinical Validation Study2024-04-11T15:32:26-05:00

New Members Join the Board of Directors

October 19, 2023, 13:03 GMT New Members Join the Board of Directors Each of them brings important experiences from their accomplished professional [...]

New Members Join the Board of Directors2023-12-11T11:00:53-05:00
Go to Top